Journals / Annals of Medical Research / 2021 / Cilt: 28 - Sayı: 4

The relationship of preoperative and postoperative serumCEA and CA 19-9 levels with tumor localization, stage andoverall survival in patients with colorectal cancer

Pages
726–732
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Overall survival (OS) and Disease Free Survival (DFS) rates were estimated using the Kaplan–Meiermethod.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: To evaluate the prognostic value of pre/postoperative serum levels of Carcinoembryonic antigen (CEA), Carbohydrate antigen19-9 (CA 19-9), and their relationship with primary localization and stage of colorectal cancer (CRC) patients.Materials and Methods: 255 patients who underwent curative or palliative surgery with the diagnosis of CRC between 2015 and 2020were included in the study.
📊
Key Findings & Data:Baseline data on age, sex, location of primary tumor, disease stage, histological differentiation, BRAF and RASmutation situations and serum CEA and CA 19-9 levels were recorded before and after surgery.
💡
Conclusion & Impact:Overall survival (OS) and Disease Free Survival (DFS) rates were estimated using the Kaplan–Meiermethod.
🔬Design:Research Article
📍Scope:2015 Verileri
⚙️Variables:Domain Parameters

Abstract

Aim: To evaluate the prognostic value of pre/postoperative serum levels of Carcinoembryonic antigen (CEA), Carbohydrate antigen19-9 (CA 19-9), and their relationship with primary localization and stage of colorectal cancer (CRC) patients.Materials and Methods: 255 patients who underwent curative or palliative surgery with the diagnosis of CRC between 2015 and 2020were included in the study. The patients were divided into groups as right colon tumor and left colon tumor based on the region ofthe primary tumor. Baseline data on age, sex, location of primary tumor, disease stage, histological differentiation, BRAF and RASmutation situations and serum CEA and CA 19-9 levels were recorded before and after surgery. Individuals were followed for at leastsixty months or until they died. Overall survival (OS) and Disease Free Survival (DFS) rates were estimated using the Kaplan–Meiermethod. Results: 103 patients had right sided (41.4%) and 152 patients (59.6%) had left sided CRC. Most of the patients were in the early stage(71%). DFS and OS patients with left colon tumors were longer than the right. [(DFS, 32.18 (6-60) vs. 34.25 (6-60) months, p=0.332)and (OS, 41.16 (6-60) vs. 49.05 (11-60) months, p=0.002]. An assessment of the prognosis showed that the OS was significantlyworse in the patients with a high CEA level (p=0.001) and in the patients with a high CA 19-9 level (p=0.001). In multivariate analysis,normal serum CA 19-9 levels (p=0.002), RAS wild type tumor (p

🔖

Cite This Article

İNCİ, F., KARATAŞ, F. (2022). The relationship of preoperative and postoperative serumCEA and CA 19-9 levels with tumor localization, stage andoverall survival in patients with colorectal cancer. Annals of Medical Research, Cilt: 28 - Sayı: 4, 726–732. https://ajindex.com/articles/445784

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394-424
  2. Siegel RL, Miller KD, Fedewa SA, et al. Colorectal cancer statistics. CA Cancer J Clin 2017;67:177-93
  3. Nordlinger B. European Colorectal Metastases Treatment Group; Sixth International Colorectal Liver Metastases Workshop. Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panel. Ann Oncol 2009;20:985-92
  4. Saleh K, Khalife-Saleh N, Kourie HR, et al. How and when adjuvant treatment should be intensified in stage III colorectal cancers? Future Oncol 2017;13:1999- 2006
  5. Al-Hajeili M, Marshall JL, Smaglo BG. Neoadjuvant treatment for surgically resectable metastatic colorectal cancer. Oncology 2016;30
  6. Kemeny MM, Adak S, Gray B, et al. Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy—an intergroup study. J Clin Oncol 2002;20:1499-505
  7. Holch JW, Ricard I, Stintzing S, et al. The relevance of primary tumour location in patients with metastatic colorectal cancer: a meta-analysis of first-line clinical trials. Eur J Cancer 2017;70:87-98
  8. Karatas. F, Sahin S. Rekürren Kolorektal Kanserli Hastalarda Primer Tümör Lokalizasyonu Ve Sağkalim Arasindaki İlişki The relationship Between Primary Tumor Localization and Survival in Patients with Recurrent Colorectal Cancer. Bozok Tıp Dergisi 2019;9:11-5
  9. Forones NM, Tanaka M. CEA and CA 19-9 as prognostic indexes in colorectal cancer. Hepato-gastroenterology 1999;46:905-8
  10. Uehara M, Manaka D, Baba S, et al. Prognostic study of preoperative serum levels of CEA and CA 19-9 in colorectal cancer. Gan to Kagaku Ryoho 2007;34:1413
  11. Jia J, Zhang P, Gou M, et al. The role of serum Cea and Ca19-9 in efficacy evaluations and progressionfree survival predictions for patients treated with cetuximab combined with Folfox4 or Folfiri as a firstline treatment for advanced colorectal cancer. Dis markers 2019;1
  12. Zhang L-N, OuYang P-Y, Xiao W-W, et al. Elevated CA19-9 as the most significant prognostic factor in locally advanced rectal cancer following neoadjuvant chemoradiotherapy. Medicine 2015;94
  13. Shibutani M, Maeda K, Nagahara H, et al. Significance of CEA a